Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03942484 · ClinicalTrials.gov registry record · NA

Efficacy of rPMS for Improvement of Urinary Incontinence and Female Sexual Function

A NA study of Urinary Incontinence, sponsored by BTL Industries.

Completed
Registry status
NA
Development phase
45
Enrollment target
5
Study locations

NCT03942484 is a NA study of Urinary Incontinence that has completed, run by BTL Industries. The registered enrollment target is 45 participants, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (83% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03942484, a NA study of Urinary Incontinence, has completed, sponsored by BTL Industries.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
5
Study locations

Study Summary

Evaluation of the repetitive pulse magnetic stimulation (rPMS) for the treatment of urinary incontinence and a female sexual satisfaction.

Conditions Studied

Interventions

  • DEVICE rPMS device

Study Locations (5)

Kentucky

  • Julene Samuels - Louisville

Michigan

  • Joseph Berenholz - Farmington Hills

New Jersey

  • Gynecological Solutions - Hillsborough

South Carolina

  • Southern Urogynecology - West Columbia

Texas

  • Hillcroft Medical Clinic - Sugar Land

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2019-05-01
Est. Completion 2021-10-20
Phase NA

Sponsor

BTL Industries

40 total trials

What the Registry Record Tells You About NCT03942484

The ClinicalTrials.gov registry entry for NCT03942484 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (83% lower). The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which rPMS device is the first listed.

NCT03942484 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Kentucky, Michigan, New Jersey.

Frequently Asked Questions

What is clinical trial NCT03942484 about?

NCT03942484 is a clinical study titled "Efficacy of rPMS for Improvement of Urinary Incontinence and Female Sexual Function". Evaluation of the repetitive pulse magnetic stimulation (rPMS) for the treatment of urinary incontinence and a female sexual satisfaction.

What is the current status of trial NCT03942484?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-05-01. Estimated completion is 2021-10-20.

What conditions does trial NCT03942484 study?

This clinical trial studies the following conditions: Urinary Incontinence.

What interventions are being tested in trial NCT03942484?

The interventions under investigation include: rPMS device (DEVICE).

Who is sponsoring clinical trial NCT03942484?

This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03942484 being conducted?

This trial has 5 study locations across Kentucky, Michigan, New Jersey, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.